Skip to main navigation
  • Therapeutic Focus
    • Genetic Disorders
    • Oncology
    • Additional Resources
      • US Expanded Access Policy
  • About PTC
    • Our Science
      • Nonsense Readthrough
      • Alternative Splicing Program
      • Transcript Regulators
    • Our History
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
    • Collaborations
    • Contact Us
    • Locations
    • PTC STRIVE Awards Program
      • Program Overview
      • Review Committee
      • STRIVE for DMD
      • FAQs
  • Pipeline
    • Ataluren (Translarna™)
      • Ataluren Publications
      • Ataluren FAQ
    • BMI1 - PTC596
    • SMA Program – RG7916
    • Clinical Trials: ataluren
      • DMD Clinical Trial Overview
  • Investors

    Investor header menu

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
    • Annual Report and Proxy
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact Us
PTC Therapeutics
  • Therapeutic Focus
    • Genetic Disorders
    • Oncology
    • Additional Resources
      • US Expanded Access Policy
  • About PTC
    • Our Science
      • Nonsense Readthrough
      • Alternative Splicing Program
      • Transcript Regulators
    • Our History
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
    • Collaborations
    • Contact Us
    • Locations
    • PTC STRIVE Awards Program
      • Program Overview
      • Review Committee
      • STRIVE for DMD
      • FAQs
  • Pipeline
    • Ataluren (Translarna™)
      • Ataluren Publications
      • Ataluren FAQ
    • BMI1 - PTC596
    • SMA Program – RG7916
    • Clinical Trials: ataluren
      • DMD Clinical Trial Overview
  • Investors

    Investor header menu

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
    • Annual Report and Proxy
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact Us

10-K

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 16, 2017
Document Date
Dec 31, 2016
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
PTC Therapeutics, Inc.
Issuer
PTC THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financial Information
  • Annual Report and Proxy
  • Stock Information
  • Investor FAQs
  • Contact Us

Shareholder Tools

Shareholder Tools

Printed Materials
Email Alerts
Downloads
RSS
Print
Share
  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS
SitemapContactLocationcareers © 2019 PTC Therapeutics. All rights reserved.